Company
LON:DEMG
Deltex Medical manufactures and markets CardioQ-ODM™ Oesophageal Doppler Monitoring (ODM) systems. ODM is the only therapy to measure blood flow in the central circulation in real time. Minimally invasive, easy to set up and quick to focus, the technology generates a low-frequency ultrasound signal, which is highly sensitive to changes in flow and measures them immediately. Randomised Controlled Trials (RCTs), using Doppler, have demonstrated that early fluid management intervention can reduce postoperative complications, reduce intensive care admissions and reduce the length of hospital stay.
122 stories · page 4 of 7
Investments and investor services
FTSE 100 stocks closed sharply lower on Friday – with losers topping 50% of the market for the first time this year - as US election jitters came to a head, non-farm payrolls Stateside did little to bolster global markets, and sterling rose
The window for all appeals against Sirius Minerals' North Yorkshire project has ended, Tower Resources raises £1.03mln of new capital and Avation has reported record revenues.
US sales of its surgical blood flow probes jumped 39%
Epistem formally changes its name, a double dose of good news for Tissue Regenix and Sound Energy's Tendrara project 'above expectations'.
The study put Deltex’s CardioQ-ODM technology head-to-head with and an uncalibrated pulse pressure waveform analysis monitor
TomCo has secured an extension to a construction permit, Kibo has completed mining feasibility studies and SolGold is set to receive some investment.
Chairman Nigel Keen described 2016 as a transitional year for the Deltex, but highlighted that expansion in the US was progressing well.
Deltex sings up two new US accounts, W Resources unveils its maiden resource estimate for the São Martinho Gold Deposit, while Cloudtag gets some major retailers on board.
It came as premier index FTSE100 was losing ground as China inflation data disappointed.
"Adoption rates in the USA, our key territory for development, continue to outperform our other areas,” said chief executive Ewan Phillips.
Deltex Medical Group has hailed the “superb results”, Tissue Regenix beefs up its board and MySQUAR updates on the success of its first game.
The top flight dropped 65 points to 6,165 and in small-cap land the FTSE AIM 100 eased 0.5% to 3,470.
Investments and investor services
Full-year results were a shade on the disappointing side for LondonMetric
The results confirm the unique ability of ODM to help doctors eliminate more than half of dangerous complications after surgery
Investments and investor services
The top flight dropped 39.92 points to 6190.87 after an ICM phone poll showed Leave taking the lead
Deltex has now signed up five US hospitals so far in the US in 2016 to make the total now 22.
ITM Power announced that London's first hydrogen refuelling station is to open next week, Westminster Group awaits the arrival of the Sierra Princess and Deltex Medical reconfigures its probe tip.
The new TruFlow probe has been used in all new customer trials in the US since November.
Archive
Strong order pipeline for Ergomed, Breedon Aggregates plans to address concerns and Mariana Resources withdraws from its Suriname gold project.
